<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51598">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02434471</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00061735</org_study_id>
    <nct_id>NCT02434471</nct_id>
  </id_info>
  <brief_title>Single Breath Hold Abdominal MRI</brief_title>
  <official_title>Single Breath Hold Abdominal MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate a single breath hold abdominal MRI protocol and
      compare the image quality of respiratory triggered 3D T1-weighted images against
      conventional breath hold images.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 12, 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motion artifact scores</measure>
    <time_frame>During MRI, up to 60 minutes</time_frame>
    <description>Two investigators will independently evaluate MRI examinations. They will assign motion scores between respiratory triggered and corresponding breath hold acquisitions. 1 = no motion artifact; 2 = minimal motion artifact, no effect on diagnostic quality; 3 = moderate motion artifact with some, but not severe, effect on diagnostic quality; 4 = severe motion artifact, images degraded but interpretable; and 5 = extensive motion artifact, images nondiagnostic</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Image quality score</measure>
    <time_frame>During MRI, up to 60 minutes</time_frame>
    <description>Image quality will be graded on a 5-point scale:
5 - excellent 4 - good, clinically acceptable 3 - fair, mild clinical limitations 2 - poor, substantially limited clinically
1 - non-diagnostic</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Abdominal MRI</condition>
  <arm_group>
    <arm_group_label>Breath hold Liver Acquisition with Volume Acquisition (LAVA)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will undergo abdominal MRI with LAVA with conventional breath holds (typically four or more breath holds) per standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Respiratory-triggered T1w DISCO LAVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respiratory-triggered T1w DISCO LAVA</intervention_name>
    <description>The study will acquire extra image sets using DISCO LAVA with one breath hold during the arterial imaging phase. No additional breath holds will be required.
Respiratory-triggered T1w DISCO LAVA precontrast
Respiratory-triggered T1w DISCO LAVA in the portal venous phase
Respiratory-triggered T1w DISCO LAVA in the equilibrium phase</description>
    <arm_group_label>Respiratory-triggered T1w DISCO LAVA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing abdominal MRI

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mustafa R Bashir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mustafa R Bashir, MD</last_name>
    <phone>919.684.7663</phone>
    <email>mustafa.bashir@dm.duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>DukeUMC</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa R Bashir, MD</last_name>
      <phone>919-684-7663</phone>
      <email>mustafa.bashir@dm.duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mustafa R Bashir, MD</last_name>
      <phone>919.684.7663</phone>
      <email>mustafa.bashir@dm.duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 23, 2017</lastchanged_date>
  <firstreceived_date>April 28, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
